Fingerprint
Dive into the research topics of 'A randomised Phase II trial of neoadjuvant chemotherapy in resectable pancreatic cancer: Gemcitabine combined with cisplatin'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A randomised Phase II trial of neoadjuvant chemotherapy in resectable pancreatic cancer: Gemcitabine combined with cisplatin
Daniel Palmer, Deborah Stocken, Helen Hewitt, Catherine Markham, AB Hassan, Philip Johnson, John Buckels, Simon Bramhall
Research output: Contribution to journal › Article
169
Citations
(Scopus)